Targeting DNA-PKCS and B7-H1 to treat cancer
US11504376B2 · kind B2 · utility
0Cited by
116References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 12, 2019 |
| Grant date | Nov 22, 2022 |
| Priority date | — |
| Expiry date | Aug 8, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Materials and methods for treating potentially chemoresistant tumors (e.g., using DNA-PKcs inhibitors and anti-B7-H1 antibodies) are provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.